Acetonitrile → HCID 46239062、化合物
反応式
[CH3:1][N:2]1[C:7](=[O:8])[C:6]2=[C:9](SC)[N:10]([CH2:12][C:13]3[CH:18]=[CH:17][C:16]([C:19]4[CH:24]=[CH:23][CH:22]=[C:21]([F:25])[N:20]=4)=[CH:15][CH:14]=3)[N:11]=[C:5]2[N:4]2[C@H:28]3[CH2:33][CH2:32][CH2:31][C@H:29]3[N:30]=[C:3]12.O[O:35][S:36]([O-:38])=O.[K+].[CH3:40]C#N>CO>[CH3:1][N:2]1[C:7](=[O:8])[C:6]2=[C:9]([S:36]([CH3:40])(=[O:38])=[O:35])[N:10]([CH2:12][C:13]3[CH:14]=[CH:15][C:16]([C:19]4[CH:24]=[CH:23][CH:22]=[C:21]([F:25])[N:20]=4)=[CH:17][CH:18]=3)[N:11]=[C:5]2[N:4]2[C@H:28]3[CH2:33][CH2:32][CH2:31][C@H:29]3[N:30]=[C:3]12参加物
5
実験手順
(6aR,9aS)-5,6a,7,8,9,9a-hexahydro-5-methyl-3-(methylthio)-2-(4-(6-fluoropyridin-2-yl)benzyl)-cyclopent[4,5]imidazo[1,2-a]pyrazolo[4,3-e]pyrimidin-4(2H)-one (35.2 mg, 0.076 mmol) is dissolved in CH3CN (0.5 mL) and CH3OH (2 mL), and then an aqueous solution of oxone (139 mg, 0.226 mmol) is added. The reaction mixture is stirred at room temperature for 2 days, and then purified by a semi-preparative HPLC to give pure product as white solids. MS (ESI) m/z 495.2 [M+H]+.
後処理
- custompurified by a semi-preparative HPLC
- customto give pure product as white solids
出典と根拠
- ORDレコード
- ord-f73c338e0b9c4619908dfe5c8a124e2e
- 出典データセット
- uspto-grants-2013_09
- 特許番号
- US08536159B2
反応ノート
読み込み中…